全文获取类型
收费全文 | 63376篇 |
免费 | 4564篇 |
国内免费 | 1642篇 |
专业分类
耳鼻咽喉 | 96篇 |
儿科学 | 1459篇 |
妇产科学 | 677篇 |
基础医学 | 3047篇 |
口腔科学 | 501篇 |
临床医学 | 8097篇 |
内科学 | 21008篇 |
皮肤病学 | 184篇 |
神经病学 | 736篇 |
特种医学 | 1576篇 |
外国民族医学 | 9篇 |
外科学 | 7968篇 |
综合类 | 10795篇 |
现状与发展 | 6篇 |
预防医学 | 2438篇 |
眼科学 | 87篇 |
药学 | 6129篇 |
48篇 | |
中国医学 | 3386篇 |
肿瘤学 | 1335篇 |
出版年
2024年 | 47篇 |
2023年 | 1001篇 |
2022年 | 1323篇 |
2021年 | 2341篇 |
2020年 | 2392篇 |
2019年 | 2164篇 |
2018年 | 2071篇 |
2017年 | 2041篇 |
2016年 | 2095篇 |
2015年 | 2198篇 |
2014年 | 4390篇 |
2013年 | 4682篇 |
2012年 | 3590篇 |
2011年 | 4165篇 |
2010年 | 3322篇 |
2009年 | 3394篇 |
2008年 | 3277篇 |
2007年 | 3367篇 |
2006年 | 3014篇 |
2005年 | 2741篇 |
2004年 | 2110篇 |
2003年 | 1838篇 |
2002年 | 1545篇 |
2001年 | 1425篇 |
2000年 | 1097篇 |
1999年 | 920篇 |
1998年 | 765篇 |
1997年 | 698篇 |
1996年 | 675篇 |
1995年 | 616篇 |
1994年 | 609篇 |
1993年 | 441篇 |
1992年 | 391篇 |
1991年 | 399篇 |
1990年 | 319篇 |
1989年 | 321篇 |
1988年 | 297篇 |
1987年 | 214篇 |
1986年 | 182篇 |
1985年 | 198篇 |
1984年 | 160篇 |
1983年 | 94篇 |
1982年 | 112篇 |
1981年 | 101篇 |
1980年 | 92篇 |
1979年 | 85篇 |
1978年 | 61篇 |
1977年 | 57篇 |
1976年 | 49篇 |
1975年 | 28篇 |
排序方式: 共有10000条查询结果,搜索用时 203 毫秒
21.
Kewei Li Fanwen Jiang Matthew Aizpuru Ellen L. Larson Xiaolong Xie Rongxing Zhou Bo Xiang 《Medicine》2021,100(6)
Optimal treatment of patients with various types of liver tumors or certain liver diseases frequently demands major liver resection, which remains a clinical challenge especially in children.Eighty seven consecutive pediatric liver resections including 51 (59%) major resections (resection of 3 or more hepatic segments) and 36 (41%) minor resections (resection of 1 or 2 segments) were analyzed. All patients were treated between January 2010 and March 2018. Perioperative outcomes were compared between major and minor hepatic resections.The male to female ratio was 1.72:1. The median age at operation was 20 months (range, 0.33–150 months). There was no significant difference in demographics including age, weight, ASA class, and underlying pathology. The surgical management included functional assessment of the future liver remnant, critical perioperative management, enhanced understanding of hepatic segmental anatomy, and bleeding control, as well as refined surgical techniques. The median estimated blood loss was 40 ml in the minor liver resection group, and 90 ml in major liver resection group (P < .001). Children undergoing major liver resection had a significantly longer median operative time (80 vs 140 minutes), anesthesia time (140 vs 205 minutes), as well as higher median intraoperative total fluid input (255 vs 450 ml) (P < .001 for all). Fourteen (16.1%) patients had postoperative complications. By Clavien-Dindo classification, there were 8 grade I, 4 grade II, and 2 grade III-a complications. There were no significant differences in complication rates between groups (P = .902). Time to clear liquid diet (P = .381) and general diet (P = .473) was not significantly different. There was no difference in hospital length of stay (7 vs 7 days, P = .450). There were no 90-day readmissions or mortalities.Major liver resection in children is not associated with an increased incidence of postoperative complications or prolonged postoperative hospital stay compared to minor liver resection. Techniques employed in this study offered good perioperative outcomes for children undergoing major liver resections. 相似文献
22.
23.
《Diagnostic Histopathology》2022,28(2):69-78
Well-differentiated hepatocellular mass-lesions in non-cirrhotic livers have a differential diagnosis of focal nodular hyperplasia, regenerative hepatic pseudotumors, hepatic adenoma, hepatocellular carcinoma, and fibrolamellar carcinoma. Despite significant advances in characterizing these pseudotumors and tumors, they remain a diagnostic challenge, especially on needle biopsy. This review focuses on a systematic diagnostic approach, one that allows confident diagnosis of these lesions. 相似文献
24.
25.
《Journal of vascular and interventional radiology : JVIR》2022,33(11):1301-1312.e13
PurposeTo assess the critical role of transjugular intrahepatic portosystemic shunt (TIPS) in the management of Budd-Chiari syndrome (BCS), as the data with respect to the safety and outcome of TIPS in patients with BCS are scarce because of the rarity of the disease.Materials and MethodsA comprehensive search of literature of various databases from 2000 to October 2021 was conducted for studies evaluating the outcome of TIPS in patients with BCS. The primary outcomes of the analysis were technical and clinical success, adverse events and mortality associated with TIPS, dysfunction of TIPS, need for TIPS revision, need for liver transplantation (LT), and 1-year survival.ResultsA total of 33 studies (1,395 patients) were included in this meta-analysis. The pooled rates and 95% confidence intervals of various outcomes were 98.6% (97.6–99.7) for technical success, 90.3% (86.0–94.6) for clinical success, 10.0% (6.5–13.6) for major adverse events, 0.5% (0.2–1.0) for TIPS-related mortality, 11.6% (7.8–15.4) for post-TIPS hepatic encephalopathy (HE), 40.1% (32.5–47.7) for TIPS dysfunction, 8.6% (4.9–12.4) for the need for TIPS revision, 4.5% (2.8–6.2) for the need for LT, and 94.6% (93.1–96.1) for 1-year survival. Publication bias was seen with all outcomes except for post-TIPS HE, TIPS dysfunction, and the need for LT.ConclusionsThe existing literature supports the feasibility, safety, and efficacy of TIPS in the treatment of BCS. Deciding the optimal timing of TIPS in BCS needs further studies. 相似文献
26.
27.
目的探讨前瞻性护理干预在急性心力衰竭患者中的应用效果。方法选取2018年4月—2020年5月河南省某医院收治的122例急性心力衰竭患者为研究对象,采用随机数字表法分为观察组与对照组,每组61例。对照组患者采用常规护理,观察组患者采用前瞻性护理,比较2组患者的干预效果、并发症发生情况,干预前后焦虑自评量表(SAS)、抑郁自评量表(SDS)评分及护理满意度。结果观察组患者干预总有效率为95.08%,高于对照组的75.41%,差异有统计学意义(χ2=9.385,P=0.002)。观察组患者并发症发生率为3.28%,低于对照组的18.03%,差异有统计学意义(χ2=6.974,P=0.008)。2组患者干预后SAS及SDS评分均低于干预前,且观察组低于对照组,差异均有统计学意义(P<0.05)。观察组患者护理满意度为98.36%,高于对照组的86.89%,差异有统计学意义(χ2=4.319,P=0.038)。结论前瞻性护理干预用于急性心力衰竭患者,有助于改善患者负性情绪及减少并发症的发生。 相似文献
28.
《Journal of vascular and interventional radiology : JVIR》2022,33(12):1507-1512
PurposeTo assess clinical outcomes and patency after transjugular intrahepatic portosystemic shunt (TIPS) reduction for overshunting adverse events.Materials and MethodsThis multicenter, retrospective observational study included 33 patients (male-to-female ratio, 20:13; mean age, 59 years; mean Model for End-Stage Liver Disease [MELD] score, 15) who underwent TIPS reduction between 2007 and 2020. Procedure indications included medically refractory hepatic encephalopathy (HE) (85%), post-TIPS hepatic insufficiency (HI) (12%), and heart failure (3%). The measured outcomes included improvement in HE (classified using the West Haven system) and HI, patency of reduced TIPS, and transplant-free survival (TFS).ResultsTIPS reductions were successfully performed using parallel stent (94%) or other (6%) techniques at a median of 120 days after TIPS creation (HE, median, 164 days; HI, median, 5 days). The portosystemic pressure gradient increased from a mean of 10 to 17 mm Hg (P < .001). The overall HE rate after TIPS reduction was 54%; HE was persistent, improved, and resolved in 21%, 32%, and 46% cases, respectively. In patients with HI, the MELD score increased from a mean of 22 before TIPS to 34 after TIPS (P = .061), but without improvement (0%) in HI after TIPS reduction (mean MELD score, 30; P = .266). Recurrent ascites occurred in 14% of the patients. The median shunt patency was 961 days (95% confidence interval, 476–1,447). The 30-day, 6-month, 1-year, and 3-year shunt patency rates were 92%, 81%, 74%, and 37%, respectively. The median TFS was not reached. The 30-day, 6-month, 1-year, and 3-year survival rates were 97%, 90%, 81%, and 60%, respectively.ConclusionsAlthough TIPS reduction may be an effective and durable approach to treat post-TIPS medically refractory HE, shunt reduction may not achieve meaningful benefit for HI. 相似文献
29.
30.